| Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades O Togao, T Yoshiura, J Keupp, A Hiwatashi, K Yamashita, K Kikuchi, ... Neuro-oncology 16 (3), 441-448, 2014 | 403 | 2014 |
| MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance Y Guan, M Mizoguchi, K Yoshimoto, N Hata, T Shono, SO Suzuki, Y Araki, ... Clinical Cancer Research 16 (16), 4289-4297, 2010 | 219 | 2010 |
| Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma K Yoshimoto, M Mizoguchi, N Hata, H Murata, R Hatae, T Amano, ... Frontiers in oncology 2, 186, 2012 | 142 | 2012 |
| Platelet-derived growth factor BB mediates the tropism of human mesenchymal stem cells for malignant gliomas N Hata, N Shinojima, J Gumin, R Yong, F Marini, M Andreeff, FF Lang Neurosurgery 66 (1), 144-157, 2010 | 128 | 2010 |
| Prevalence and clinicopathological features of H3. 3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution K Yoshimoto, R Hatae, Y Sangatsuda, SO Suzuki, N Hata, Y Akagi, ... Brain tumor pathology 34, 103-112, 2017 | 83 | 2017 |
| Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma X Ma, K Yoshimoto, Y Guan, N Hata, M Mizoguchi, N Sagata, H Murata, ... Neuro-oncology 14 (9), 1153-1162, 2012 | 74 | 2012 |
| Clinical implications of microRNAs in human glioblastoma M Mizoguchi, Y Guan, K Yoshimoto, N Hata, T Amano, A Nakamizo, ... Frontiers in oncology 3, 19, 2013 | 72 | 2013 |
| Molecular characteristics of glioblastoma with 1p/19q co-deletion M Mizoguchi, K Yoshimoto, X Ma, Y Guan, N Hata, T Amano, A Nakamizo, ... Brain tumor pathology 29, 148-153, 2012 | 49 | 2012 |
| Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data R Hatae, N Hata, K Yoshimoto, D Kuga, Y Akagi, H Murata, SO Suzuki, ... PLoS One 11 (8), e0160489, 2016 | 44 | 2016 |
| MicroRNAs in human malignant gliomas M Mizoguchi, Y Guan, K Yoshimoto, N Hata, T Amano, A Nakamizo, ... Journal of oncology 2012, 2012 | 43 | 2012 |
| A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology R Hatae, N Hata, SO Suzuki, K Yoshimoto, D Kuga, H Murata, Y Akagi, ... Neuropathology 37 (3), 191-199, 2017 | 42 | 2017 |
| Loss of heterozygosity analysis in malignant gliomas M Mizoguchi, D Kuga, Y Guan, N Hata, A Nakamizo, K Yoshimoto, ... Brain tumor pathology 28, 191-196, 2011 | 40 | 2011 |
| Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues D Kuga, M Mizoguchi, Y Guan, N Hata, K Yoshimoto, T Shono, SO Suzuki, ... Neuro-oncology 10 (6), 995-1003, 2008 | 38 | 2008 |
| Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis N Hata, K Yoshimoto, N Yokoyama, M Mizoguchi, T Shono, Y Guan, ... Clinical chemistry 52 (3), 370-378, 2006 | 38 | 2006 |
| 4D ASL-based MR angiography for visualization of distal arteries and leptomeningeal collateral vessels in moyamoya disease: a comparison of techniques O Togao, A Hiwatashi, M Obara, K Yamashita, D Momosaka, A Nishimura, ... European radiology 28, 4871-4881, 2018 | 35 | 2018 |
| Fine-tuning approach for segmentation of gliomas in brain magnetic resonance images with a machine learning method to normalize image differences among facilities S Takahashi, M Takahashi, M Kinoshita, M Miyake, R Kawaguchi, ... Cancers 13 (6), 1415, 2021 | 34 | 2021 |
| Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid Y Fujioka, N Hata, Y Akagi, D Kuga, R Hatae, Y Sangatsuda, Y Michiwaki, ... Journal of Neuro-oncology 152, 47-54, 2021 | 34 | 2021 |
| Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive IDH1 mutant gliomas. A Natsume, T Wakabayashi, Y Miyakita, Y Narita, Y Mineharu, Y Arakawa, ... Journal of Clinical Oncology 37 (15_suppl), 2004-2004, 2019 | 32 | 2019 |
| TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations H Arita, Y Matsushita, R Machida, K Yamasaki, N Hata, M Ohno, ... Acta neuropathologica communications 8, 1-11, 2020 | 31 | 2020 |
| Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR K Yoshimoto, X Ma, Y Guan, M Mizoguchi, A Nakamizo, T Amano, N Hata, ... Brain tumor pathology 28, 291-296, 2011 | 31 | 2011 |
